The Original Investigation titled “Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial,”1 published on August 2, 2023, was corrected to fix the labels in the key for Figure 1. This article was corrected online.
Reference
- 1.Lee SJ, Cha JJ, Choi WG, et al. ; RACING Investigators . Moderate-intensity statin with ezetimibe combination therapy vs high-intensity statin monotherapy in patients at very high risk of atherosclerotic cardiovascular disease: a post hoc analysis from the RACING randomized clinical trial. JAMA Cardiol. Published online August 2, 2023. doi: 10.1001/jamacardio.2023.2222 [DOI] [PMC free article] [PubMed] [Google Scholar]